bioAffinity Technologies, Inc. (BIAF) analyst actions
Rating and price-target actions on BIAF in the public-source dataset. Wires and filings carry few rating actions, so this list is sparse by nature — the hub's by-event-type table holds the measured analyst base rates. Back to the BIAF overview →
2 measured BIAF analyst action events.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath® Lung Cancer Diagnostic | Press release | -5.13% | +2.59% | |
| bioAffinity Technologies’ Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation | Press release | +0.77% | -0.77% |
Keep exploring
More BIAF: earnings → · SEC filings → · BIAF overview →